Key result
Lysophosphatidylcholine (LPC) induced myocardial injury in diabetic cardiomyopathy through the TLR4/ZNF480/AP-1/NF-kB pathway.
Why the study?
The specific mechanisms through which lysophosphatidylcholine induces myocardial injury in diabetic cardiomyopathy remain elusive.
Case-Control (n=117)
Answers are grounded in this paper and cite their sources.
LPC pathway findings in DC warrant mechanistic follow-up; leaves open clinical validation before diagnostic or therapeutic use.
Background: Diabetic cardiomyopathy (DC), a frequent complication of type 2 diabetes mellitus (T2DM), is mainly associated with severe adverse outcomes. Previous research has highlighted the role of Lysophosphatidylcholine (LPC) in inducing myocardial injury; however, the specific mechanisms through which LPC mediate such injury in DC remain elusive. The existing knowledge gap underscores the need for additional clarification. Consequently, this study aimed to explore the impact and underlying mechanisms of LPC on myocardial injury in DC. Methods: A total of 55 patients diagnosed with T2DM and 62 healthy controls were involved. A combination of 16s rRNA sequencing, metabolomic analysis, transcriptomic RNA-sequencing (RNA-seq), and whole exome sequencing (WES) was performed on fecal and peripheral blood samples collected from the participants. Following this, correlation analysis was carried out, and the results were further validated through the mouse model of T2DM. Results: expression level was downregulated. Lastly, myocardial injury was identified in T2DM mice. Conclusions: The results indicated that LPC could induce myocardial injury in DC through the TLR4/ZNF480/AP-1/NF-kB pathway, providing a precise target for the clinical diagnosis and treatment of DC.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted a case-control in Type 2 diabetes mellitus and diabetic cardiomyopathy (n=117). Lysophosphatidylcholine (LPC) vs. Healthy controls was evaluated on Myocardial injury and pathway expression. Lysophosphatidylcholine (LPC) induced myocardial injury in diabetic cardiomyopathy through the TLR4/ZNF480/AP-1/NF-kB pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: